Status:
COMPLETED
Study Evaluating HKI-272 Administered to Healthy Subjects
Lead Sponsor:
Puma Biotechnology, Inc.
Conditions:
Healthy
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
Safety and tolerability of HKI-272 in healthy subjects; the influence of food intake on the same.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Healthy
Exclusion
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT00366600
Start Date
July 1 2006
End Date
December 1 2006
Last Update
September 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwest Kinetics
Tacoma, Washington, United States, 98418